Frontlight ResearchEarly access
Primary biliary cholangitis trials in Hong Kong
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSeladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 402 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01